ArticleFrontiers in cardiovascular medicine2022

Human embryonic stem cell-derived endothelial cell product injection attenuates cardiac remodeling in myocardial infarction.

Ana-Mishel Spiroski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.